Basem Azab, MD, on Esophageal Cancer: Study Survival Results

2018 Gastrointestinal Cancers Symposium
Tweet this page

Basem Azab, MD, of the Sylvester Comprehensive Cancer Center, University of Miami, discusses the impact on overall survival when more than 2 months elapse between finishing neoadjuvant therapy and undergoing esophagectomy (Abstract 2).

Advertisement

Advertisement



Advertisement